2002 Gordon Research Conference on Hemostasis

2002 年戈登止血研究会议

• 批准号: 6530265
• 负责人: David Ginsburg
• 金额: $ 1万
• 依托单位: GORDON RESEARCH CONFERENCES
• 依托单位国家: 美国
• 财政年份: 2002
• 资助国家: 美国
• 起止时间: 2002-06-01 至 2003-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6530265
• 关键词: health science research; hemostasis; meeting /conference /symposium

DESCRIPTION (provided by applicant): This is a proposal to support the 2002 Hemostasis Gordon Conference to be held at Colby College in Waterville, MA from July 7-12 2002. This conference has been held since 1973 and has a long-standing tradition of providing a forum for the presentation and discussion of research in the field of hemostasis. Research in this area continues and will continue to have important implications for human health and disease and is a central focus for funding by the NHLBI. The Gordon Research Conference provides an ideal setting for interactions between basic researchers, clinical investigators, and translational physical scientists from academic as well as the pharmaceutical and biotechnology industries. The 2002 conference will continue the tradition of presenting the best available cutting edge research in Hemostasis. Topics to be covered during the invited lecture sessions and poster presentations will include: 1) regulation of platelet biosynthesis and megakaryocytopoiesis, 2) mechanisms of platelet signaling and regulation of cytoskeleton, 3) structure and function of coagulation factors, 4) genetics of inherited bleeding and clotting disorders, 5) thrombotic thrombocytopenic purpura and the ADAMTS13 protease, 6) new therapeutic approaches to the treatment of thrombosis and hemorrhage, 7) the role of vessel wall in hemostasis, and 8) new genomic and postgenomic approaches to hemostasis. The extensive interactions and discussion that will occur at this conference will help identify new areas and directions for future research.

描述(由申请人提供)：这是一项支持2002年止血戈登会议的提案，会议将于2002年7月7日至12日在马萨诸塞州沃特维尔的科尔比学院举行。这次会议自1973年以来一直举行，有一个长期的传统，即为介绍和讨论止血领域的研究提供一个论坛。这一领域的研究仍在继续，并将继续对人类健康和疾病产生重要影响，是NHLBI资助的中心重点。戈登研究会议为来自学术以及制药和生物技术行业的基础研究人员、临床研究人员和转化物理科学家之间的互动提供了理想的环境。2002年的会议将延续介绍止血方面现有最先进研究成果的传统。1)血小板生物合成和巨核细胞生成的调节，2)血小板信号和细胞骨架调节的机制，3)凝血因子的结构和功能，4)遗传性出血和凝血障碍的遗传学，5)血栓性血小板减少性紫癜和ADAMTS13蛋白酶，6)治疗血栓形成和出血的新治疗方法，7)血管壁在止血中的作用，8)新的基因组和后基因组止血方法。这次会议将进行广泛的互动和讨论，这将有助于确定未来研究的新领域和方向。